Autologous Transplant in HIV Patients (BMT CTN 0803)

NCT01141712 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
HIV

Interventions

PROCEDURE: Autologous transplant
DRUG: BCNU
DRUG: Etoposide
DRUG: Cytarabine
DRUG: Melphalan

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]